Biotech billionaire appoints Dane as CEO of growing drug group
![Christoffer Lorenzen takse position as CEO in Karo Pharma on July 1, 2019. | Foto: Ritzau Scanpix/Niels Hougaard](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11296322.ece/ALTERNATES/schema-16_9/20170624-145539-pf-1920x1279we.jpg)
Danish biotech billionaire Bo Jesper Hansen, who earned his fortune by merging his firm Swedish Orphan and Biovitrum and sell his shares, does not rest on his laurels.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.